Xuebin began his research in stem cell in 2006 when he was studying for his master degree. After his graduation from Beijing XIehe Medicine College for his doctor degree in 2009, he began his clinical research and treatment of stem cell transplantation. He has accumulated rich clinical experience in stem cell diagnosis of neural systemic diseases and mastered the relative operations of stem cell transplantation surgery.
1.Xuebin Liu, Hou J, Shi L, Chen J, Sang J, Hu S, Cong X, Chen X. Lysophosphatidic acid protects mesenchymal stem cells against ischemia-induced apoptosis in vivo. Stem Cells Dev. 2009; 18(7): 947-54
2.Li Z, Wei H, Xuebin Liu, Hu S, Cong X, Chen X. LPA rescues ER stress-associated apoptosis in hypoxia and serum deprivation-stimulated mesenchymal stem cells. J Cell Biochem. 2010, ;111(4): 811-20
3.Yu Nie, Bian-mei Han, Xuebin Liu, Jin-jing Yang, Fang Wang, Xiang-feng Cong, Xi Chen. Identification of MicroRNAs Involved in Hypoxia and Serum Deprivation-Induced Apoptosis in Mesenchymal Stem Cells. International Journal of Biological Sciences. 2011;7(6):762-768
4.Yin Q, Jin P, Xuebin Liu, Wei H, Lin X, Chi C, Liu Y, Sun C, Wei Y. SDF-1alpha inhibits hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells through PI3K/Akt and ERK1/2 signaling pathways. Mol Biol Rep. 2011, 38(1): 9-16
5.Zhang G, Zhou J, Fan Q, Zheng Z, Zhang F, Xuebin Liu, Hu S. Arterial-venous endothelial cell fate is related to vascular endothelial growth factor and Notch status during human bone mesenchymal stem cell differentiation. FEBS Lett. 2008; 582(19): 2957-64
6.Chen J, Baydoun AR, Xu R, Deng L, Xuebin Liu, Zhu W, Shi L, Cong X, Hu S, Chen X. Lysophosphatidic acid protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis. Stem Cells. 2008; 26(1):135-45